Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Efficacy Studies Randomized Controlled Trials Cancer Treatment Cancer Research

4 ARTICLES

6h ago

House Select Committee Opens National-Security Inquiries Into Merck and AbbVie China Trials

The committee has asked both companies for documents by July 17 to evaluate whether trials in Xinjiang and at military hospitals pose ethical, data and intellectual-property risks.

3 ARTICLES

8h ago

Study Maps How Leukemia Enters Lungs and Identifies Drug Targets

Stories older than 24h

3 ARTICLES

yesterday

FDA Approves Lumvoa for Thyroid Eye Disease

10 ARTICLES

2d ago

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

3 ARTICLES

3d ago

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

4 ARTICLES

4d ago

EMA Committee Recommends Revoking Tavneos Authorization

3 ARTICLES

5d ago

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

4 ARTICLES

5d ago

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

8 ARTICLES

6d ago

Most IVF Add‑Ons Show Little or No Proven Benefit, Major Lancet Review Finds

9 ARTICLES

last wk.

Regulator Agrees Minimum Ages for UK Puberty‑Blocker Trial but Recruitment Remains Paused

14 ARTICLES

last wk.

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

3 ARTICLES

last wk.

OpenAI Model Helps Boston Children’s Reanalyse Genomes to Yield 18 New Diagnoses

6 ARTICLES

last wk.

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

6 ARTICLES

last wk.

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

4 ARTICLES

last wk.

University of Michigan Performs First Permanent Human Implant of Paradromics’ Wireless Brain Chip

3 ARTICLES

last wk.

University of Minnesota Wins $2.2M NEI Grant to Study Fibulin-3 in Retinal Disease

5 ARTICLES

2w ago

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Clinical Trials

House Select Committee Opens National-Security Inquiries Into Merck and AbbVie China Trials

Study Maps How Leukemia Enters Lungs and Identifies Drug Targets

FDA Approves Lumvoa for Thyroid Eye Disease

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

EMA Committee Recommends Revoking Tavneos Authorization

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

Most IVF Add‑Ons Show Little or No Proven Benefit, Major Lancet Review Finds

Regulator Agrees Minimum Ages for UK Puberty‑Blocker Trial but Recruitment Remains Paused

Never miss stories about

Clinical Trials

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

OpenAI Model Helps Boston Children’s Reanalyse Genomes to Yield 18 New Diagnoses

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

FDA Expands Capvaxive Use to At‑Risk Children and Teens

Biogen to Buy RayThera for Up to $1 Billion

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

University of Michigan Performs First Permanent Human Implant of Paradromics’ Wireless Brain Chip

University of Minnesota Wins $2.2M NEI Grant to Study Fibulin-3 in Retinal Disease

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Never miss stories about

Clinical Trials